Trials / Not Yet Recruiting
Not Yet RecruitingNCT07339956
Yiwei Jiaohuang Ointment for Gastrointestinal Bleeding Associated With Oral Antithrombotic Agents
Yiwei Jiaohuang Ointment for Gastrointestinal Bleeding Associated With Oral Antithrombotic Agents: A Randomized Controlled Trial
- Status
- Not Yet Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- China-Japan Friendship Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to evaluate the clinical efficacy and safety of YiWei Jiaohuang Ointment in treating gastrointestinal bleeding associated with oral antithrombotic therapy. The main question it aims to answer is: Does Yiwei JiaoHuang Ointment accelerate the conversion to negative results in fecal occult blood tests among patients with gastrointestinal bleeding associated with antithrombotic therapy? Researchers will compare use rabeprazole alone as routine therapy to see if Yiwei JiaoHuang Ointment can accelerate the conversion to negative results in fecal occult blood tests. Participants will : Take Yiwei JiaoHuang Ointment every day for 2 weeks. Return to the hospital for a fecal occult blood test after 3 days, 1 week, and 2 weeks of medication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | A Chinese herb formula--Yiwei Jiaohuang Onitment | Yiwei Jiaohuang Onitment consists of four Chinese herbs: 3g of Duyiwei(Lamiophlomis Herb), 3g of raw Da Huang(Rhubarb Root and Rhizome (Unprocessed)), 6g of Bai Ji(Bletilla Rhizome) and 10g of Ejiao (donkey-hide gelatin). Prepared as ointment, patients should take one dose daily in the morning on an empty stomach for 2 weeks. |
| DRUG | Rabeprazole Enteric-Coated Tablets | Rabeprazole Enteric-Coated Tablets10mg once a day for 2 weeks |
Timeline
- Start date
- 2026-01-10
- Primary completion
- 2026-08-01
- Completion
- 2026-08-30
- First posted
- 2026-01-14
- Last updated
- 2026-01-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07339956. Inclusion in this directory is not an endorsement.